Angiogenesis-related microRNAs in colon cancer

Bibliography

• Schetter AJ, Harris CC. Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol 2011;38(6):734-42
   PubMed Web of Science ®Google Scholar
• Graham JS, Cassidy J. Adjuvant therapy in colon cancer. Expert Rev Anticancer Ther 2012;12(1):99-109
   PubMed Web of Science ®Google Scholar
• Kanwar JR, Mahidhara G, Kanwar RK. Antiangiogenic therapy using nanotechnological-based delivery system. Drug Discov Today 2011;16(5-6):188-202
   PubMed Web of Science ®Google Scholar
• Hong L, Li S, Han Y, Angiogenesis-related molecular targets in esophageal cancer. Expert Opin Investig Drugs 2011;20(5):637-44
   PubMed Web of Science ®Google Scholar
• Hong L, Han Y, Li S, The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas. Expert Opin Biol Ther 2010;10(12):1693-701
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Z, Chen M, MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer. Mol Cancer 2012;11(1):23
   PubMed Web of Science ®Google Scholar
• Weissmann-Brenner A, Kushnir M, Lithwick Yanai G, Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer. Int J Oncol 2012;40(6):2097-103
   PubMed Web of Science ®Google Scholar
• Okamoto K, Ishiguro T, Midorikawa Y, miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver. EMBO J 2012;31(7):1752-63
   PubMed Web of Science ®Google Scholar
• Wu WK, Law PT, Lee CW, MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis 2011;32(3):247-53
   PubMed Web of Science ®Google Scholar
• Yamakuchi M, Lotterman CD, Bao C, P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci USA 2010;107(14):6334-9
   PubMed Web of Science ®Google Scholar
• Sansom SE, Nuovo GJ, Martin MM, miR-802 regulates human angiotensin II type 1 receptor expression in intestinal epithelial C2BBe1 cells. Am J Physiol Gastrointest Liver Physiol 2010;299(3):G632-42
   PubMed Web of Science ®Google Scholar
• Xu Q, Liu LZ, Qian X, MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res 2012;40(2):761-74
   PubMed Web of Science ®Google Scholar
• Sundaram P, Hultine S, Smith LM, p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers. Cancer Res 2011;71(24):7490-501
   PubMed Web of Science ®Google Scholar
• Pathi SS, Jutooru I, Chadalapaka G, GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway. Mol Cancer Res 2011;9(2):195-202
   PubMed Web of Science ®Google Scholar
• Vuorio T, Jauhiainen S, Yla-Herttuala S. Pro- and anti-angiogenic therapy and atherosclerosis with special emphasis on vascular endothelial growth factors. Expert Opin Biol Ther 2012;12(1):79-92
   PubMed Web of Science ®Google Scholar
• Jahangiri A, Aghi MK. Biomarkers predicting tumor response and evasion to anti-angiogenic therapy. Biochim Biophys Acta 2012;1825(1):86-100
   PubMed Web of Science ®Google Scholar
• Pohl M, Werner N, Munding J, Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature. Z Gastroenterol 2011;49(10):1398-406
   PubMed Web of Science ®Google Scholar
• Gardlik R, Celec P, Bernadic M. Targeting angiogenesis for cancer (gene) therapy. Bratisl Lek Listy 2011;112(8):428-34
   PubMed Web of Science ®Google Scholar
• Hong L, Han Y, Li S, Role of ZNRD1 (zinc ribbon domain-containing 1) in angiogenesis of leukaemia cells. Cell Biol Int 2011;35(4):321-4
   PubMed Web of Science ®Google Scholar
• Biyashev D, Qin G. E2F and microRNA regulation of angiogenesis. Am J Cardiovasc Dis 2011;1(2):110-18
   Google Scholar
• Hong L, Han Y, Zhang H, The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann Surg 2010;251:1056-63
   PubMed Web of Science ®Google Scholar
• Caporali A, Emanueli C. MicroRNA regulation in angiogenesis. Vascul Pharmacol 2011;55(4):79-86
   PubMed Web of Science ®Google Scholar
• Yang W, Lee DY, Ben-David Y. The roles of microRNAs in tumorigenesis and angiogenesis. Int J Physiol Pathophysiol Pharmacol 2011;3(2):140-55
   PubMedGoogle Scholar
• Piao L, Zhang M, Datta J, Lipid-based nanoparticle delivery of pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma. Mol Ther 2012;20(6):1261-9
   PubMed Web of Science ®Google Scholar
• Cicatiello L, Mutarelli M, Grober OM, Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs. Am J Pathol 2010;176(5):2113-30
   PubMed Web of Science ®Google Scholar
• Inoue T, Iinuma H, Ogawa E, Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol Rep 2012;27(6):1759-64
   PubMed Web of Science ®Google Scholar
• Feng L, Xie Y, Zhang H, miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. Med Oncol 2012;29(2):856-63
   PubMed Web of Science ®Google Scholar
• Chen PS, Su JL, Cha ST, miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. J Clin Invest 2011;121(9):3442-55
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Y, Shi Y, MicroRNA-107, an oncogene microRNA that regulates tumor invasion and metastasis by targeting DICER1 in gastric cancer. J Cell Mol Med 2011;15(9):1887-95
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Forrest AR, Maeno E, MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One 2009;4(8):e6677
   PubMed Web of Science ®Google Scholar
• Lee KH, Lotterman C, Karikari C, Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 2009;9(3):293-301
   PubMed Web of Science ®Google Scholar
• Bruemmer D, Daugherty A, Lu H, Relevance of angiotensin II-induced aortic pathologies in mice to human aortic aneurysms. Ann NY Acad Sci 2011;1245:7-10
   PubMed Web of Science ®Google Scholar
• Lin DH, Yue P, Pan C, MicroRNA 802 stimulates ROMK channels by suppressing caveolin-1. J Am Soc Nephrol 2011;22(6):1087-98
   PubMed Web of Science ®Google Scholar
• Ibrahim AF, Weirauch U, Thomas M, MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 2011;71(15):5214-24
   PubMed Web of Science ®Google Scholar
• Liu R, Liao J, Yang M, The cluster of miR-143 and miR-145 affects the risk for esophageal squamous cell carcinoma through co-regulating fascin homolog 1. PLoS One 2012;7(3):e33987
   PubMedGoogle Scholar
• Li JM, Zhao RH, Li ST, Down-regulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer. Saudi Med J 2012;33(1):24-9
   PubMed Web of Science ®Google Scholar
• Zhu H, Dougherty U, Robinson V, EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators. Mol Cancer Res 2011;9(7):960-75
   PubMed Web of Science ®Google Scholar
• Jia Y, Liu H, Zhuang Q, Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145. Oncol Rep 2012;27(6):1865-72
   PubMed Web of Science ®Google Scholar
• Koo S, Martin GS, Schulz KJ, Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines. BMC Cancer 2012;12(1):143
   PubMedGoogle Scholar
• Lee SJ, Kim SJ, Seo HH, Over-expression of miR-145 enhances the effectiveness of HSVtk gene therapy for malignant glioma. Cancer Lett 2012;320(1):72-80
   PubMed Web of Science ®Google Scholar
• Kim SJ, Oh JS, Shin JY, Development of microRNA-145 for therapeutic application in breast cancer. J Control Release 2011;155(3):427-34
   PubMed Web of Science ®Google Scholar
• Zhang J, Guo H, Qian G, MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network. Mol Cancer 2010;9:211
   PubMedGoogle Scholar
• Ostenfeld MS, Bramsen JB, Lamy P, miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors. Oncogene 2010;29(7):1073-84
   PubMed Web of Science ®Google Scholar
• Arndt GM, Dossey L, Cullen LM, Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 2009;9:374
   PubMed Web of Science ®Google Scholar
• Pekow JR, Dougherty U, Mustafi R, miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes. Inflamm Bowel Dis 2012;18(1):94-100
   PubMed Web of Science ®Google Scholar
• Kahlert C, Klupp F, Brand K, Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases. Cancer Sci 2011;102(10):1799-807
   PubMed Web of Science ®Google Scholar
• Jenkins RH, Martin J, Phillips AO, Transforming growth factor beta1 represses proximal tubular cell microRNA-192 expression through decreased hepatocyte nuclear factor DNA binding. Biochem J 2012;443(2):407-16
   PubMedGoogle Scholar
• Senanayake U, Das S, Vesely P, miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. Carcinogenesis 2012;33(5):1014-21
   PubMed Web of Science ®Google Scholar
• Krutzfeldt J, Rosch N, Hausser J, MicroRNA-194 is a target of transcription factor 1 (Tcf1, HNF1alpha) in adult liver and controls expression of frizzled-6. Hepatology 2012;55(1):98-107
   PubMed Web of Science ®Google Scholar
• Hino K, Tsuchiya K, Fukao T, Inducible expression of microRNA-194 is regulated by HNF-1alpha during intestinal epithelial cell differentiation. RNA 2008;14(7):1433-42
   PubMed Web of Science ®Google Scholar
• Xu J, Kang Y, Liao WM, MiR-194 regulates chondrogenic differentiation of human adipose-derived stem cells by targeting Sox5. PLoS ONE 2012;7(3):e31861
   PubMed Web of Science ®Google Scholar
• Dong P, Kaneuchi M, Watari H, MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer 2011;10:99
   PubMed Web of Science ®Google Scholar
• Urbich C, Kaluza D, Fromel T, MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood 2012;119(6):1607-16
   PubMed Web of Science ®Google Scholar
• Ji J, Zhang J, Huang G, Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 2009;583(4):759-66
   PubMed Web of Science ®Google Scholar
• Zhang H, Li Y, Huang Q, MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. Cell Death Differ 2011;18(11):1702-10
   PubMed Web of Science ®Google Scholar
• Zhao X, Yang L, Hu J. Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells. J Exp Clin Cancer Res 2011;30:55
   PubMed Web of Science ®Google Scholar
• Zhang H, Li M, Han Y, Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig Dis Sci 2010;55(9):2545-51
   PubMed Web of Science ®Google Scholar
• Spruck C. miR-27a regulation of SCF(Fbw7) in cell division control and cancer. Cell Cycle 2011;10(19):3232-3
   PubMed Web of Science ®Google Scholar
• Ma Y, Yu S, Zhao W, miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett 2010;298(2):150-8
   PubMed Web of Science ®Google Scholar
• Wang Q, Li DC, Li ZF, Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen. Oncogene 2011;30(36):3875-86
   PubMed Web of Science ®Google Scholar
• Li X, Mertens-Talcott SU, Zhang S, MicroRNA-27a indirectly regulates estrogen receptor {alpha} expression and hormone responsiveness in MCF-7 breast cancer cells. Endocrinology 2010;151(6):2462-73
   PubMed Web of Science ®Google Scholar
• Sun Q, Gu H, Zeng Y, Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci 2010;101(10):2241-7
   PubMed Web of Science ®Google Scholar
• Kim TD, Lee SU, Yun S, Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity. Blood 2011;118(20):5476-86
   PubMed Web of Science ®Google Scholar